May 31, 2017
Related News
Other posts that you should not miss.
Positive early data from the BRIDGE1 study, a three-year 1000+ patient study in bronchiectasis funded by the …
June 3, 2019
Dr David Ribeiro, CEO of ProAxsis, will be attending the Bio-Europe Spring meeting, taking place in Barcelona on …
March 6, 2017
The potential benefits of ProAxsis’ novel ProteaseTag® Active Proteinase 3 Immunoassay will be discussed at the Winter meeting …
November 26, 2018